ATOPIC DERMATITIS (ECZEMA)

 

ATOPIC DERMATITIS (ECZEMA)

 

DEFINITION:

An inflammatory disorder of the skin initiated by an IgE-mediated hypersensitivity.

EPIDEMIOLOGY:

  • incidence: 2-5% of children
  • age of onset:
    • 80% of patients present by 1 year of age (rare before 2 months)
    • 90% " 5 "
  • risk factors:
    • 67% have a positive family history of atopy (asthma, hayfever, urticaria)
  • associations:
    • an allergic triad
      • 50-80% of patients with atopic dermatitis will go on to develop asthma and/or allergic rhinitis, i.e., atopic dermatitis may be the forerunner for the development of other allergic diseases

PATHOGENESIS:

1. Allergy

1. Background

  • allergy is the manifestation of a hypersensitive reaction to the presentation of an allergen due to the propensity of the affected individual to develop a sustained IgE response following antigenic stimulation
  • the distinguishing feature of the allergic individual is the propensity to develop a sustained IgE response - there are several types of allergies based upon where the hypersensitive reaction occurs:

Surface-Allergy

  • Nasal Mucosa-Allergic Rhinitis
  • Skin-Hives (Urticaria), Atopic Dermatitis
  • Respiratory Tract-Allergic Asthma
  • Systemic-Anaphylaxis

2. Allergens

  • allergens are compounds capable of inducing human IgE antibody formation ("sensitization")

3. IgE

  • IgE is a Homocytotropic Antibody: an antibody capable of interacting with target cells such that these cells release mediators on contact with specific antigens
  • the IgE receptor consists of an externally located alpha chain that binds the IgE and is noncovalently associated with a beta chain and two gamma chains
  • there are two categories of IgE receptors dependent upon the type of cells targetted and the type of mediators re-leased from these cells:

1. Type 1

  • target cells - mast cells, basophils
  • affinity - high affinity for IgE
  • mediators - histamine, ECF-A, leukotrienes, bradykinins, prostaglandins, PAF, anaphylatoxins

2. Type 2

  • target cells - lymphocytes, platelets, eosino-phils, monocytes-macrophages
  • affinity - low affinity for IgE
  • mediators - chemotaxic factors, IgE binding factors (T cells), mitogens (B cells), inflammatory mediators

2. Atopic Dermatitis

1. Background

  • an allergy specific to the skin in susceptible individuals

2. Allergens

1. Internal

  • eczema triggered from ingested allergens
1. Foods
  • milk, eggs, fish, peanuts, wheat, soybean, corn
2. Beverages
3. Medications

2. External

  • eczema triggered by direct contact of the allergen with the skin (contact dermatitis)
  • location of rash may help to identify the offending allergen
  • may be worse in the winter (dryness, wool, tight-fit-ting clothes) or summer (moisture)
1. Cosmetics
  • applied lotions, ointments, soaps
  • cosmetics worn by caregiver
2. Fabrics
  • bedding, car seats, changing pads, clothing (on patient or caregiver)
  • detergents, soaps, softeners used to wash the above
3. Allergens
  • housedust mites, moulds, pet dander, pollens
  • cigarette smoke, wood smoke

3. IgE

  • within the dermis of the skin a Type 2 homocytotropic antibody response occurs
  • target cells
    • lymphocytes, platelets, eosinophils, monocytes-macrophages, Langerhan cells
  • mediator responses
    • intense pruritic, erythematous, maculopapular, warm, tender eruption
    • begins at 4 hours post exposure with pruritis, peaks at 6-12 hours, and slowly resolves over
    • 24-48 hours

CLINICAL FEATURES:

1. Background

  • Atopic Dermatitis typically occurs in 3 stages each with fairly distinctive features
  • the eczema may be called the "itch that rashes" because the first symptom is itchiness of the skin with the subsequent appearance of the rash which is made worse by further scratching ("itch-scratch-rash-itch-cycle")

2. Stage 1 - Initial Phase

1. Onset

  • birth to 2 years of age with a mean of 8 months

2. Rash

  • intense pruritis with scratching
  • diffuse erythematous flush
  • erythematous weeping patches (diaper area spared)
  • dry, red, scaly plaques

3. Distribution

  • cheek with spread to face, scalp, behind ears, neck
  • extensor surfaces of the extremities (arms, wrists, hands, legs) and the abdomen

4. Associated Symptoms

  • agitation - irritability
  • colic - urticaria

3. Stage 2 - Childhood Phase

1. Onset

  • 2 to 12 years of age

2. Rash

  • intense pruritis with scratching
  • papules coalesce to form plaques
  • marked excoriation and lichenification (thickening)

3. Distribution

  • face (eyes, mouth), behind ears
  • flexural surfaces of the neck, antecubital and popliteal fossae, and wrists and ankles

4. Stage 3 - Adult Phase

1. Onset

  • greater than 12 years of age

2. Rash

  • diffuse, scaling, dried, lichenified, hyperpigmented

3. Distribution

  • whitish hue on forehead, upper eyelids (mask of atopic dermatitis)
  • flexural surfaces of the neck, antecubital and popliteal fossae
  • dorsal aspects of hands and feet

5. Signs

  • white dermographism
  • Morgan Fold - grooves below the lower eyelids
  • increased number of creases in the skin of the palm
  • sparcity of hair in the lateral portion of the eyebrow

6. Complications

1. Secondary Infections

1. Bacterial

  • streptococcal, staphylococcal

2. Viral

  • HSV (eczema herpeticum) - papilloma (warts)
  • molluscum contagiosum - vaccinia

2. Others

  • edema with lakes of serous fluid within the epidermis

INVESTIGATIONS:

1. Serum

  • elevated IgE (increased 5-10x over normal in 80% of patients)
  • eosinophilia

2. Allergy Tests

  • In Vivo - skin tests - immediate, delayed, patch skin test
  • In Vitro - Immunoassays - RAST, MAST, ELISA

MANAGEMENT:

1. Supportive

  • recognize that eczema is a chronic condition with periods of remission
  • during times of relapse may need reassurance and morale boosting
  • eczema tends to improve with age - see prognosis below
  • management is based on:
    • avoidance
    • reduce or eliminate itch
    • medications

 

2. Avoidance

1. Internal Allergens

1. Foods

1. Elimination Diet
  • if patient is breastfeeding, try eliminating certain foods from the mother's diet
  • eliminate foods that the patient is eating and always one at a time
  • eliminate the suspected food for 4-7 days and observe for clearing of the skin
  • start with the most common eczema-causing foods
  • if difficult to identify triggering food, keep a diary and begin eliminating foods taken more than three times in one week
  • a food which does cause eczema, should be kept out of the diet for 4-6 months then reintroduced to see if the eczema returns

2. Medications

  • watch for reaction to anesthetics, antibiotics, anti-depressants, antiseptics, aspirin, birth control pill, laxatives, nose drops, tranquillizers, sleeping pills, vitamins

2. External Allergens

1. Cosmetics

  • change shampoo, conditioner, tint, dye, mousse, perm, nail polish, creams, makeup, deodorant, hair products, or aerosol products

2. Fabrics

  • change clothing, bedding, towels, laundry detergent, fabric softener, bleach
  • avoid strong irritant substances (soaps, detergents, bleach, fabric softeners)
  • avoid wool with cotten the least irritating
  • look for changes in cleansing agents ("new", "im-proved") or changes in water (soft vs hard, recent travel)
  • may wash clothes in a mild laundry soap (Ivory Snow) and double rinsing may remove residual soap - prewash all new clothing and bed linens

3. Others

  • avoid strong topical sensitizers (neomycin, anti-histamines, suphonamides)
  • avoid sudden changes or extremes of temperature and humidity (hot baths, saunas)
  • avoid sudden increase in physical activity or exercise
  • avoid sudden environmental changes at home/school/work
  • avoid irritants - cigarette smoke, wood smoke

3. Eliminate Itch

1. Moisturize Skin

1. Baths

  • aids in soothing & treating eczema by removing crust, softening skin, and decreasing secondary infections - bath 2-7 times per week using emollient unscented soap (White Dove of Petro-phyllic), mild cleansers (Cetaphil or Spectro Jel), or colloidal oatmeal but not regular soaps
  • prolonged cool baths of 30 minutes are most effective
  • may use certain shampoos if scalp is affected - coal-tar shampoo
  • may apply an unscented bath oil at the end of the bath and creams and lotions after bath (lanolin-based cream or an oil-in-water cream)
  • pat dry with towel
  • avoid hot baths, talc powder, bubble baths, bath salts

2. Skin Moisturizers

  • Vasoline, Glaxal base, and Nivea cream may decrease dry skin
  • apply when skin is wet (i.e., after a bath) to seal in the moisture
  • avoid moisturizers with urea and lactic acid

2. Local Dressings

  • Burrow's Solution (1:20) to affected areas

3. Antihistamines

  • Seldane (Terfenadine), Hismanal (Astemizole), Claritin (Loratodine), Reactine (Cetirizine)
  • may be helpful by sedating as well

4. Medications

1. Topical Steroids

1. 0.1% Hydrocortisone Acetate Cream

  • first line topical steroid therapy
  • apply to affected areas bid to qid
  • side effect includes thinning of skin in area of application

2. Mometasone Furoate (Elocom)

  • 2nd line topical steroid therapy
  • apply to affected areas od

2. Antibiotics

  • for secondary bacterial infections - penicillins

5. Others

  • topical tar preparations
  • artificial UV light
  • antisuppressants
    • Prednisone, Cyclophophamide, Azathioprine, Cyclosporin

6. Prognosis

1. Poor Prognosticators

  • generalized rash - other atopic manifestations
  • onset >2 years of age - prolonged extensor limb involve-
  • females ment

2. Long-Term

  • tends to improve with age
  • if onset in Stage 1, most are quiescent by 5 years of age, with 40% going into remission by 2-3 years of age - if onset in Stage 3, 50% of patient have lost eczema by age 21 and marked tendency towards lasting remission in the 4th and 5th decades

 

 

Pediatric Database - ATOPIC DERMATITIS (ECZEMA)

Pediatric Organization - Pedbase [at] Gmail.com